Mice implanted with gliomas expressing both IL-10 and IL-2 had significantly smaller (99% smaller) tumor sizes and increased T-cell infiltration at 14 days post-implantation compared to mice with IL-10−/IL-2− tumors (38). This evidence concerns the gene IL10 and neoplasm.